STOCK TITAN

Core Scientific (CORZ) appoints Jorge Ray as Principal Accounting Officer with equity grant

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Core Scientific, Inc. has appointed Jorge Ray as its Principal Accounting Officer, effective May 7, 2026. He currently serves as Chief Accounting Officer, a role he has held since March 2026, and brings prior senior accounting experience from Raymond James Financial, BankUnited, KPMG, and PwC.

His compensation includes a base salary of $400,000, a target annual bonus equal to 40% of base salary, a one-time grant of restricted stock units valued at $600,000 that vest over three years, and a one-time signing bonus of $193,000, including $71,000 for relocation expenses.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Base salary $400,000 per year Compensation for Principal Accounting Officer role
Target bonus 40% of base salary Eligibility under annual bonus program
RSU grant value $600,000 Restricted stock units vesting over three years
Signing bonus $193,000 One-time signing bonus including relocation
Relocation component $71,000 Portion of signing bonus for relocation expenses
Warrant exercise price CORZW $6.81 per share Each whole warrant exercisable for one share
Warrant exercise price CORZZ $0.01 per share Each whole warrant exercisable for one share
Effective date of appointment May 7, 2026 Start date as Principal Accounting Officer
Principal Accounting Officer financial
"the Board of Directors ... appointed Jorge Ray as the Company’s Principal Accounting Officer"
The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.
restricted stock units financial
"Mr. Ray also received a one-time grant of restricted stock units with a grant date value of $600,000"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Item 5.02 regulatory
"Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers"
emerging growth company regulatory
"Emerging growth company Item 5.02 — Departure of Directors or Certain Officers"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Nasdaq Global Select Market market
"The Nasdaq Global Select Market Warrants, each whole warrant exercisable for one share"
A Nasdaq Global Select Market listing is the highest tier of stocks on the Nasdaq exchange, reserved for companies that meet the strictest financial, reporting and governance standards. For investors, it acts like a premium quality label—signaling larger, more transparent and better-governed companies that tend to offer greater liquidity and lower perceived risk compared with lower-tier listings, making it easier to buy, sell and evaluate shares.
0001839341FALSECore Scientific, Inc./tx838 Walker RoadSuite 21-2105DoverDelaware00018393412026-04-302026-05-050001839341us-gaap:CommonStockMember2026-04-302026-05-050001839341core:WarrantExercisePriceOf6.81PerShareMember2026-04-302026-05-050001839341core:WarrantExercisePriceOf0.01PerShareMember2026-04-302026-05-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 30, 2026
Core Scientific, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-40046 86-1243837
(State or other jurisdiction
of incorporation)
 (Commission
File Number)
 (IRS Employer
Identification No.)
838 Walker Road, Suite 21-2105
Dover, Delaware
 
19904
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (512) 402-5233

(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.00001 per share
CORZ
The Nasdaq Global Select Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $6.81 per share         
CORZW
The Nasdaq Global Select Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $0.01 per share
CORZZ
The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 30, 2026, the Board of Directors of Core Scientific, Inc. (the “Company”) appointed Jorge Ray as the Company’s Principal Accounting Officer, effective May 7, 2026.
Mr. Ray, age 43, currently serves as Chief Accounting Officer of the Company and has held this position since March 2026.
Prior to joining the Company, Mr. Ray served as Corporate Controller at Raymond James Financial, Inc. from April 2025 to March 2026, overseeing accounting and financial reporting. Before that, he served as Executive Vice President and Chief Accounting Officer at BankUnited, Inc. from May 2017 to April 2025.
Mr. Ray previously worked at KPMG LLP and PricewaterhouseCoopers LLP, specializing in audit services for financial institutions.
Mr. Ray holds a Master of Business Administration from the MIT Sloan School of Management.
In connection with his employment as Chief Accounting Officer, Mr. Ray’s compensation consists of an annual base salary of $400,000 and eligibility to participate in the Company’s annual bonus program with a target bonus opportunity of 40% of his base salary. Mr. Ray also received a one-time grant of restricted stock units with a grant date value of $600,000, which vest over three years, and a one-time signing bonus of $193,000, including $71,000 for relocation expenses. Mr. Ray remains eligible for future equity awards under the Company’s compensation programs.
There are no arrangements or understandings between Mr. Ray and any other persons pursuant to which he was appointed as Principal Accounting Officer. There are no family relationships between Mr. Ray and any director or executive officer of the Company, and there are no transactions involving Mr. Ray that would require disclosure under Item 404(a) of Regulation S-K.
Item 9.01    Financial Statement and Exhibits
(d) Exhibits:
  
Exhibit
No.
Description
104Cover Page Interactive Data File (embedded within the Inline XBRL document).





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Core Scientific, Inc.
Dated: May 5, 2026
By:/s/ Todd M. DuChene
Name:Todd M. DuChene
Title:Chief Legal Officer and Chief Administrative Officer


FAQ

What did Core Scientific (CORZ) announce in this 8-K filing?

Core Scientific announced the appointment of Jorge Ray as Principal Accounting Officer, effective May 7, 2026. The filing outlines his background, new role, and detailed compensation package, including salary, bonus eligibility, equity awards, and a signing bonus with relocation support.

Who is Jorge Ray, the new Principal Accounting Officer of Core Scientific (CORZ)?

Jorge Ray is Core Scientific’s Chief Accounting Officer, becoming Principal Accounting Officer on May 7, 2026. He previously served as Corporate Controller at Raymond James Financial and Chief Accounting Officer at BankUnited, and holds an MBA from the MIT Sloan School of Management.

What is the compensation package for Core Scientific’s new Principal Accounting Officer?

Jorge Ray will receive a $400,000 base salary, with a target annual bonus of 40% of salary. He also receives $600,000 in restricted stock units vesting over three years and a $193,000 signing bonus, which includes $71,000 for relocation expenses.

What stock and warrant securities of Core Scientific are listed on Nasdaq?

Core Scientific lists common stock on the Nasdaq Global Select Market under symbol CORZ. It also lists warrants under CORZW, exercisable at $6.81 per share, and warrants under CORZZ, exercisable at $0.01 per share.

Filing Exhibits & Attachments

4 documents